Canaccord Genuity Maintains HealthStream at Hold, Raises Price Target to $32
Canaccord Genuity has maintained its 'Hold' rating on HealthStream, Inc. while increasing the price target from $29 to $32.
Stocks · News reference
HealthStream Increases Fiscal Year 2026 Guidance
Alongside its third-quarter earnings report, HealthStream announced an increase to its full-year 2026 revenue and adjusted EBITDA guidance.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- fiscal.ai
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Craig-Hallum Downgrades HealthStream to Hold
Craig-Hallum downgraded HealthStream from buy to hold, citing valuation concerns despite positive quarterly results.
HealthStream Declares Quarterly Dividend
HealthStream, Inc. has declared a quarterly cash dividend of $0.035 per share.
HealthStream Announces Third Quarter 2026 Results
HealthStream, Inc. reported its financial results for the third quarter ended September 30, 2026, showing revenue growth alongside changes in operating and net income.
8-K filing — HEALTHSTREAM INC (HSTM)
Filed: 2026-11-02 AccNo: 0001437749-26-034455 Size: 479 KB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
HealthStream, Inc. Scheduled to Report Q3 2026 Financial Results
HealthStream, Inc. has announced it will release its financial results for the third quarter of 2026 on November 2, 2026.